Yuhan

Yuhan Gross Margin

The Gross Margin of Yuhan (000100.KS) as of Nov 18, 2026 is 33.38 %. In the previous year, Gross Margin was 33.34 % — a change of 0.12% (higher).

Gross Margin

33.38 %

YoY

0.12%

Last updated:

Gross Margin of Yuhan is 2025 33.38 % . Gross Margin of Yuhan was 2024 33.34 % . It decreases by 0.12% higher compared to the previous year.

For Yuhan, the gross margin of 33.4% is up versus 31.1% a few years ago.

The Yuhan Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
27.24 KRW
Jan 1, 2019
29.10 KRW
Jan 1, 2020
34.47 KRW
Jan 1, 2021
31.08 KRW
Jan 1, 2022
29.18 KRW
Jan 1, 2023
30.44 KRW
Jan 1, 2024
33.34 KRW
Jan 1, 2025
33.38 KRW
The Yuhan Gross Margin history
YEARGross MarginYoY
33.38 %+0.12%
33.34 %+9.53%
30.44 %+4.31%
29.18 %-6.13%
31.08 %-9.83%
34.47 %+18.45%
29.10 %+6.83%
27.24 %-6.18%
29.04 %-1.51%
29.49 %-2.00%
30.09 %-2.67%
30.91 %+9,857.66%
0.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yuhan Stock analysis

What does Yuhan do? The Yuhan Corporation is a South Korean conglomerate that was founded on September 1, 1926, under the name "Chosun Pharmaceutical Company". The company is headquartered in Seoul and employs more than 5,000 people worldwide. History: The Yuhan Corporation started as a small company with a single product, a fish oil-based ointment called "Yuksundo". The company worked hard to improve its products and expand its market, eventually expanding into other business areas such as the production of antibiotics and diabetes treatments. In the early 1950s, the company also ventured into the research and development of other pharmaceuticals. In 1962, Yuhan became a publicly traded company and received a variety of awards in the following years, including several Korean Industrial Awards. Since its inception, the company has remained committed to improving people's lives through innovation and science. Business model: The Yuhan Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of drugs and other health products. The company also makes investments in innovative technologies and healthcare startups. Over the years, Yuhan has expanded its business through partnerships with other companies and acquisitions of companies such as LGL Holdings and SillaJen Inc. The company also engages in international business relations, such as selling its products and medications in other countries. Divisions: The Yuhan Corporation has four main business divisions: Medical Research and Development, Drug Manufacturing, Biotechnology Product Development, and Health Product Production. The first division is coordinated by Yuhan Research & Development Co. Ltd, while drug manufacturing is done by Yuhan Manufacturing Co. Ltd. Biotechnology is done by Yuhan Biomedical Research Institute, and the health product segment is handled by Yuhan Healthcare. Products: Yuhan's products are diverse and include a wide range of drugs and health products. The company is involved in the production of antibiotics, analgesics, vein treatment agents, diabetes medications, cardiovascular drugs, and other pharmaceutical products. Other products also include cosmetics, oral care products, and dermatology drugs. Some of Yuhan's well-known products include the antibiotic Ceclor, a medication for the treatment of diabetes and metabolic disorders, as well as apple-based cosmetic products. All Yuhan products are manufactured according to strict quality standards and are known for their effectiveness and safety. Conclusion: The Yuhan Corporation has evolved into a diverse and innovative company focused on the production of drugs and health products. The company has a long history with many successes and has established itself as one of the major forces in the South Korean economy over the past decades. Yuhan's mission to create better healthcare remains as relevant today as it was at the time of its founding. Yuhan is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yuhan stock

Gross Margin of Yuhan is 33.38 % in 2025.

Gross Margin of Yuhan changed from 33.34 % to 33.38 %, representing a 0.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Yuhan since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Yuhan with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Yuhan

All Key Metrics — Yuhan